Pages that link to "Q38423572"
Jump to navigation
Jump to search
The following pages link to Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. (Q38423572):
Displaying 30 items.
- The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma (Q26750641) (← links)
- Epigenome-based personalized medicine in human cancer (Q28083951) (← links)
- Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion (Q33771084) (← links)
- Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer (Q34521462) (← links)
- Squamous cell cancer of the esophagus: the forgotten one. (Q34758867) (← links)
- Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling (Q35152228) (← links)
- Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis (Q35172269) (← links)
- Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel (Q35184495) (← links)
- RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel (Q35551978) (← links)
- RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker (Q35786661) (← links)
- Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth (Q36355895) (← links)
- Mitochondrial ATP 6 and 8 polymorphisms in irritable bowel syndrome with diarrhea (Q36975067) (← links)
- Methylation of TFPI-2 is an early event of esophageal carcinogenesis (Q37091635) (← links)
- Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma (Q37354050) (← links)
- The value of epigenetic markers in esophageal cancer (Q37812294) (← links)
- Epigenetic biomarkers in esophageal cancer (Q37992481) (← links)
- Review of the alterations in DNA methylation in esophageal squamous cell carcinoma (Q38071897) (← links)
- Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma (Q38093059) (← links)
- Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients (Q38649673) (← links)
- Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs (Q38849728) (← links)
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (Q39325094) (← links)
- AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. (Q39441173) (← links)
- HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme (Q41264327) (← links)
- Copy number changes of CRISP3 in oral squamous cell carcinoma (Q42143278) (← links)
- Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma (Q42643155) (← links)
- Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development (Q42776992) (← links)
- Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas. (Q51806819) (← links)
- ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. (Q55000594) (← links)
- Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma (Q58606234) (← links)
- Epigenetic based synthetic lethal strategies in human cancers (Q99711836) (← links)